株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

臨床試験市場分析:フェーズ別、研究設計別、適応別、セグメント別の予測

Clinical Trials Market Size, Share & Trends Analysis By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication, And Segment Forecasts, 2020 - 2027

発行 Grand View Research, Inc. 商品コード 557173
出版日 ページ情報 英文 120 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.69円で換算しております。
臨床試験市場分析:フェーズ別、研究設計別、適応別、セグメント別の予測 Clinical Trials Market Size, Share & Trends Analysis By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication, And Segment Forecasts, 2020 - 2027
出版日: 2020年02月10日 ページ情報: 英文 120 Pages
概要

当レポートでは、世界の臨床試験市場について調査分析し、市場概要、セグメント別の市場の見通し、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 調査手法・範囲

第2章 エグゼクティブサマリー

第3章 臨床試験市場の変数・動向・範囲

  • 市場区分・範囲
  • 市場促進要因分析
  • 市場抑制要因分析
  • 普及率・成長見通しマッピング
  • SWOT分析
  • ファイブフォース分析

第4章 臨床試験市場:フェーズ別の見通し・動向分析

  • 動向分析
  • フェーズI
  • フェーズII
  • フェーズIII
  • フェーズIV

第5章 臨床試験市場:研究設計別の見通し・動向分析

  • 動向分析
  • インターベンション
  • 観察
  • 利用範囲拡大

第6章 臨床試験市場:適応別の見通し・動向分析

  • 動向分析
  • 自己免疫/炎症
  • 疼痛管理
  • 腫瘍
  • 中枢神経系疾患
  • 糖尿病
  • 肥満
  • 心血管
  • その他

第7章 臨床試験市場:地域別の見通し・動向分析

  • 動向分析
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合情勢

  • 企業プロファイル
    • QuintilesIMS
    • Parexel International Corporation
    • Pharmaceutical Product Development, LLC
    • Charles River Laboratory
    • ICON Plc
    • Wuxi AppTec Inc.
    • PRA Health Sciences
    • Chiltern International Ltd.
    • INC Research
    • SGS SA
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Clinical Trials Market, By Region 2016 - 2027 (USD Million)
  • Table 4 Global Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 5 Global Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 7 Global Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 8 North America Clinical Trials Market, By Country, 2016 - 2027 (USD Million)
  • Table 9 North America Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 10 North America Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 12 North America Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 13 U.S. Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 14 U.S. Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 16 U.S. Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 17 Canada Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 18 Canada Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 20 Canada Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 21 Europe Clinical Trials Market, By Country, 2016 - 2027 (USD Million)
  • Table 22 Europe Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 23 Europe Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 25 Europe Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 26 U.K. Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 27 U.K. Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 29 U.K. Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 30 Germany Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 31 Germany Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 33 Germany Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 34 France Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 35 France Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 37 France Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 38 Italy Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 39 Italy Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 41 Italy Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 42 Spain Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 43 Spain Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 45 Spain Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 46 Asia Pacific Clinical Trials Market, By Country, 2016 - 2027 (USD Million)
  • Table 47 Asia Pacific Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 48 Asia Pacific Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 50 Asia Pacific Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 51 India Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 52 India Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 54 India Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 55 Japan Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 56 Japan Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 58 Japan Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 59 China Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 60 China Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 62 China Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 63 Australia Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 64 Australia Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 66 Australia Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 67 South Korea Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 68 South Korea Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 70 South Korea Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 71 Latin America Clinical Trials Market, By Country, 2016 - 2027 (USD Million)
  • Table 72 Latin America Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 73 Latin America Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 75 Latin America Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 76 Brazil Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 77 Brazil Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 79 Brazil Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 80 Mexico Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 81 Mexico Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 83 Mexico Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 84 Argentina Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 85 Argentina Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 87 Argentina Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 88 Colombia Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 89 Colombia Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 91 Colombia Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 92 MEA Clinical Trials Market, By Country, 2016 - 2027 (USD Million)
  • Table 93 MEA Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 94 MEA Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 96 MEA Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 97 South Africa Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 98 South Africa Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 100 South Africa Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 101 Saudi Arabia Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 102 Saudi Arabia Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 104 Saudi Arabia Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 105 UAE Clinical Trials Market, By Phase, 2016 - 2027 (USD Million)
  • Table 106 UAE Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 108 UAE Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Clinical Trials Market:Market snapshot
  • Fig. 9 Clinical Trials Market:Market segmentation
  • Fig. 10 Clinical Trials Market Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Clinical Trials Market driver impact
  • Fig. 14 Clinical Trials Market restraint impact
  • Fig. 15 Clinical Trials Market porter's five forces analysis
  • Fig. 16 Clinical Trials Market PESTEL analysis
  • Fig. 17 Clinical Trials Market segment dashboard
  • Fig. 18 Clinical Trials Market: Phase movement Analysis
  • Fig. 19 Phase I estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 20 Phase II estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 21 Phase III estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 22 Phase IV estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 23 Clinical Trials Market segment dashboard
  • Fig. 24 Clinical Trials Market: Study Design Movement Analysis
  • Fig. 25 Interventional market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 26 Observational market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 27 Expanded Access market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 28 Clinical Trials Market: Segment dashboard
  • Fig. 29 Clinical Trials Market: Indication movement analysis
  • Fig. 30 Autoimmune/inflammation market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 31 Pain management market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 32 Oncology market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 33 CNS condition market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 34 Diabetes market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 35 Obesity market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 36 Cardiovascular market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 37 Others market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 38 Global Clinical Trials Market: Regional movement analysis
  • Fig. 39 Global Clinical Trials Market: Regional outlook and key takeaways
  • Fig. 40 Global market share, by region
  • Fig. 41 North America market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 42 U.S. market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 43 Canada market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 44 Europe market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 45 U.K. market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 46 Germany market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 47 France market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 48 Italy market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 49 Spain market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 50 Asia Pacific market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 51 China market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 52 Japan market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 53 India market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 54 Australia market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 55 South Korea market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 56 Latin America market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 57 Brazil market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 58 Mexico market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 59 Argentina market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 60 Colombia market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 61 Middle East and Africa. market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 62 South Africa market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 63 Saudi Arabia market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 64 UAE market estimates and forecast, 2016 - 2027 (USD Million)
目次
Product Code: GVR-1-68038-975-3

The global clinical trials market size is expected to reach USD 69.8 billion by 2027, exhibiting a 5.1% CAGR during the forecast period, according to a new report published by Grand View Research, Inc. Increasing incidence of diabetes, rheumatoid arthritis, multiple sclerosis and many other chronic diseases is projected to propel the growth. Due to rising prevalence of infectious and tropical diseases in some regions, a large number of patients is participating in clinical trials to access high quality healthcare treatment free of cost.

Increasing prevalence of life-threatening allergic diseases is also expected to fuel the market growth. As per the Food Allergy Research & Education Survey 2017, around 200,000 people need emergency medical care for allergic reaction to food, mostly in U.S. In addition, government initiative has also motivated many players in market to initiate orphan drug development. Thus there are various drugs in pipeline. Rising healthcare expenditure and collaborations for the purpose of R&D activities are also expected to be other significant factors driving the market for clinical trials in the forthcoming years.

Further key findings from the report suggest:

  • Phase III clinical trials emerged as the largest segment in 2019
  • Interventional study design segment held the largest market share in 2019, owing to increasing demand for the intervention for clinical trials by researchers
  • North America dominated the clinical trials market with the largest revenue share in 2019. Increasing demand for new technologies along with advanced healthcare infrastructure are contributing to the dominance of this region
  • Asia Pacific is projected to witness the fastest growth during the forecast period owing to the increasing number of diabetic patients in this region
  • Few of the market players include IQVIA; PAREXEL International Corporation; Pharmaceutical Product Development, LLC; Charles River Laboratory; ICON Plc; Wuxi AppTec Inc.; PRA Health Sciences; SGS SA; Syneos Health; Chiltern International Ltd.; Eli Lilly and Company; Novo Nordisk A/S; Pfizer; and Clinipace

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Phase
    • 1.1.2. Study Design
    • 1.1.3. Indication
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1: Understanding the market dynamics
    • 1.9.2. Objective 2: Understanding the market estimates and forecasts
    • 1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
    • 1.9.4. Objective 4: Understanding the key product and application scopes to conclude on the market size

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Trials Market Variables, Trends & Scope

  • 3.1. Market Lineage outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Product Pipeline Analysis, by Stage
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
      • 3.4.1.1. Increasing research and development promoting outsourcing
      • 3.4.1.2. Adoption of new technology in clinical research
      • 3.4.1.3. Increasing prevalence of chronic disease
      • 3.4.1.4. Globalization of clinical trials
    • 3.4.2. Market Restraint Analysis
      • 3.4.2.1. Stringent regulatory policies for patient enrollment
      • 3.4.2.2. Lack of skilled workforce in clinical research
    • 3.4.3. Industry Challenges
      • 3.4.3.1. Rising cost of clinical trial
  • 3.5. Clinical Trials: Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier Power
      • 3.5.1.2. Buyer Power
      • 3.5.1.3. Substitution Threat
      • 3.5.1.4. Threat from new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political Landscape
      • 3.5.2.2. Environmental Landscape
      • 3.5.2.3. Social Landscape
      • 3.5.2.4. Technology Landscape
      • 3.5.2.5. Legal Landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis

Chapter 4. Clinical Trials Market: Segment Analysis, by Phase, 2016 - 2027 (USD Million)

  • 4.1. Definitions & Scope
  • 4.2. Phase market share analysis, 2019 & 2027
  • 4.3. Segment Dashboard
  • 4.4. Global Clinical Trials Market, by Phase, 2016 to 2027
  • 4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027for the following
    • 4.5.1. Phase I
    • 4.5.2. Phase II
    • 4.5.3. Phase III
    • 4.5.4. Phase IV

Chapter 5. Clinical Trials Market: Segment Analysis, By Study Design, 2016 - 2027 (USD Million)

  • 5.1. Definitions & Scope
  • 5.2. Study Design market share analysis, 2019 & 2027
  • 5.3. Segment Dashboard
  • 5.4. Global Clinical Trials Market, By Study Design, 2016 to 2027
  • 5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
    • 5.5.1. Interventional
    • 5.5.2. Observational
    • 5.5.3. Expanded Access

Chapter 6. Clinical Trials Market: Segment Analysis, By Indication, 2016 - 2027 (USD Million)

  • 6.1. Definitions & Scope
  • 6.2. Indication market share analysis, 2019 & 2027
  • 6.3. Segment Dashboard
  • 6.4. Global Clinical Trials Market, By Indication, 2016 to 2027
  • 6.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
    • 6.5.1. Autoimmune/inflammation
    • 6.5.2. Pain management
    • 6.5.3. Oncology
    • 6.5.4. CNS condition
    • 6.5.5. Diabetes
    • 6.5.6. Obesity
    • 6.5.7. Cardiovascular
    • 6.5.8. Others

Chapter 7. Clinical Trials Market: Regional Market Analysis, by Phase, 2016 - 2027 (USD Million)

  • 7.1. Definitions & Scope
  • 7.2. Regional Market Share Analysis, 2019 & 2027
  • 7.3. Regional Market Dashboard
  • 7.4. Regional Market Snapshot
  • 7.5. Regional Market Share, 2018
  • 7.6. Market Size, & Forecasts, and Trend Analysis, 2016 to 2027:
  • 7.7. North America
    • 7.7.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 7.7.2. Market estimates and forecast, by Phase, 2016 - 2027 (USD Million)
    • 7.7.3. Market estimates and forecast, by Study Design, 2016 - 2027 (USD Million)
    • 7.7.4. Market estimates and forecast, By Indication, 2016 - 2027 (USD Million)
    • 7.7.5. U.S.
      • 7.7.5.1. Market estimates and forecast, by Phase, 2016 - 2027 (USD Million)
      • 7.7.5.2. Market estimates and forecast, by Study Design, 2016 - 2027 (USD Million)
      • 7.7.5.3. Market estimates and forecast, by Indication, 2016 - 2027 (USD Million)
    • 7.7.6. Canada
      • 7.7.6.1. Market estimates and forecast, by Phase, 2016 - 2027 (USD Million)
      • 7.7.6.2. Market estimates and forecast, by Study Design, 2016 - 2027 (USD Million)
      • 7.7.6.3. Market estimates and forecast, by Indication, 2016 - 2027 (USD Million)
  • 7.8. Europe
    • 7.8.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 7.8.2. Market estimates and forecast, by Phase, 2016 - 2027 (USD Million)
    • 7.8.3. Market estimates and forecast, by Study Design, 2016 - 2027 (USD Million)
    • 7.8.4. Market estimates and forecast, by Indication, 2016 - 2027 (USD Million)
    • 7.8.5. Germany
      • 7.8.5.1. Market estimates and forecast, by Phase, 2016 - 2027 (USD Million)
      • 7.8.5.2. Market estimates and forecast, by Study Design, 2016 - 2027 (USD Million)
      • 7.8.5.3. Market estimates and forecast, by Indication, 2016 - 2027 (USD Million)
    • 7.8.6. U.K.
      • 7.8.6.1. Market estimates and forecast, by Phase, 2016 - 2027 (USD Million)
      • 7.8.6.2. Market estimates and forecast, by Study Design, 2016 - 2027 (USD Million)
      • 7.8.6.3. Market estimates and forecast, by Indication, 2016 - 2027 (USD Million)
    • 7.8.7. France
      • 7.8.7.1. Market estimates and forecast, by Phase, 2016 - 2027 (USD Million)
      • 7.8.7.2. Market estimates and forecast, by Study Design, 2016 - 2027 (USD Million)
      • 7.8.7.3. Market estimates and forecast, by Indication, 2016 - 2027 (USD Million)
    • 7.8.8. Italy
      • 7.8.8.1. Market estimates and forecast, by Phase, 2016 - 2027 (USD Million)
      • 7.8.8.2. Market estimates and forecast, by Study Design, 2016 - 2027 (USD Million)
      • 7.8.8.3. Market estimates and forecast, by Indication, 2016 - 2027 (USD Million)
    • 7.8.9. Spain
      • 7.8.9.1. Market estimates and forecast, by Phase, 2016 - 2027 (USD Million)
      • 7.8.9.2. Market estimates and forecast, by Study Design, 2016 - 2027 (USD Million)
      • 7.8.9.3. Market estimates and forecast, by Indication, 2016 - 2027 (USD Million)
  • 7.9. Asia Pacific
    • 7.9.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 7.9.2. Market estimates and forecast, by Phase, 2016 - 2027 (USD Million)
    • 7.9.3. Market estimates and forecast, by Study Design, 2016 - 2027 (USD Million)
    • 7.9.4. Market estimates and forecast, by Indication, 2016 - 2027 (USD Million)
    • 7.9.5. China
      • 7.9.5.1. Market estimates and forecast, by Phase, 2016 - 2027 (USD Million)
      • 7.9.5.2. Market estimates and forecast, by Study Design, 2016 - 2027 (USD Million)
      • 7.9.5.3. Market estimates and forecast, by Indication, 2016 - 2027 (USD Million)
    • 7.9.6. Japan
      • 7.9.6.1. Market estimates and forecast, by Phase, 2016 - 2027 (USD Million)
      • 7.9.6.2. Market estimates and forecast, by Study Design, 2016 - 2027 (USD Million)
      • 7.9.6.3. Market estimates and forecast, by Indication, 2016 - 2027 (USD Million)
    • 7.9.7. India
      • 7.9.7.1. Market estimates and forecast, by Phase, 2016 - 2027 (USD Million)
      • 7.9.7.2. Market estimates and forecast, by Study Design, 2016 - 2027 (USD Million)
      • 7.9.7.3. Market estimates and forecast, by Indication, 2016 - 2027 (USD Million)
    • 7.9.8. Australia
      • 7.9.8.1. Market estimates and forecast, by Phase, 2016 - 2027 (USD Million)
      • 7.9.8.2. Market estimates and forecast, by Study Design, 2016 - 2027 (USD Million)
      • 7.9.8.3. Market estimates and forecast, by Indication, 2016 - 2027 (USD Million)
    • 7.9.9. South Korea
      • 7.9.9.1. Market estimates and forecast, by Phase, 2016 - 2027 (USD Million)
      • 7.9.9.2. Market estimates and forecast, by Study Design, 2016 - 2027 (USD Million)
      • 7.9.9.3. Market estimates and forecast, by Indication, 2016 - 2027 (USD Million)
  • 7.10. Latin America
    • 7.10.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 7.10.2. Market estimates and forecast, by Phase, 2016 - 2027 (USD Million)
    • 7.10.3. Market estimates and forecast, by Study Design, 2016 - 2027 (USD Million)
    • 7.10.4. Market estimates and forecast, by Indication, 2016 - 2027 (USD Million)
    • 7.10.5. Brazil
      • 7.10.5.1. Market estimates and forecast, by Phase, 2016 - 2027 (USD Million)
      • 7.10.5.2. Market estimates and forecast, by Study Design, 2016 - 2027 (USD Million)
      • 7.10.5.3. Market estimates and forecast, by Indication, 2016 - 2027 (USD Million)
    • 7.10.6. Mexico
      • 7.10.6.1. Market estimates and forecast, by Phase, 2016 - 2027 (USD Million)
      • 7.10.6.2. Market estimates and forecast, by Study Design, 2016 - 2027 (USD Million)
      • 7.10.6.3. Market estimates and forecast, by Indication, 2016 - 2027 (USD Million)
    • 7.10.7. Argentina
      • 7.10.7.1. Market estimates and forecast, by Phase, 2016 - 2027 (USD Million)
      • 7.10.7.2. Market estimates and forecast, by Study Design, 2016 - 2027 (USD Million)
      • 7.10.7.3. Market estimates and forecast, by Indication, 2016 - 2027 (USD Million)
    • 7.10.8. Colombia
      • 7.10.8.1. Market estimates and forecast, by Phase, 2016 - 2027 (USD Million)
      • 7.10.8.2. Market estimates and forecast, by Study Design, 2016 - 2027 (USD Million)
      • 7.10.8.3. Market estimates and forecast, by Indication, 2016 - 2027 (USD Million)
  • 7.11. Middle East and Africa
    • 7.11.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 7.11.2. Market estimates and forecast, by Phase, 2016 - 2027 (USD Million)
    • 7.11.3. Market estimates and forecast, by Study Design, 2016 - 2027 (USD Million)
    • 7.11.4. Market estimates and forecast, by Indication, 2016 - 2027 (USD Million)
    • 7.11.5. South Africa
      • 7.11.5.1. Market estimates and forecast, by Phase, 2016 - 2027 (USD Million)
      • 7.11.5.2. Market estimates and forecast, by Study Design, 2016 - 2027 (USD Million)
      • 7.11.5.3. Market estimates and forecast, by Indication, 2016 - 2027 (USD Million)
    • 7.11.6. Saudi Arabia
      • 7.11.6.1. Market estimates and forecast, by Phase, 2016 - 2027 (USD Million)
      • 7.11.6.2. Market estimates and forecast, by Study Design, 2016 - 2027 (USD Million)
      • 7.11.6.3. Market estimates and forecast, by Indication, 2016 - 2027 (USD Million)
    • 7.11.7. UAE
      • 7.11.7.1. Market estimates and forecast, by Phase, 2016 - 2027 (USD Million)
      • 7.11.7.2. Market estimates and forecast, by Study Design, 2016 - 2027 (USD Million)
      • 7.11.7.3. Market estimates and forecast, by Indication, 2016 - 2027 (USD Million)

Chapter 8. Clinical Trials Market- Competitive Analysis

  • 8.1. Key companies profiled
    • 8.1.1. IQVIA
      • 8.1.1.1. Company Overview
      • 8.1.1.2. Financial Performance
      • 8.1.1.3. Product Benchmarking
      • 8.1.1.4. Strategic Initiatives
    • 8.1.2. PAREXEL International Corporation
      • 8.1.2.1. Company Overview
      • 8.1.2.2. Financial Performance
      • 8.1.2.3. Product Benchmarking
      • 8.1.2.4. Strategic Initiatives
    • 8.1.3. Pharmaceutical Product Development, LLC
      • 8.1.3.1. Company Overview
      • 8.1.3.2. Financial Performance
      • 8.1.3.3. Product Benchmarking
      • 8.1.3.4. Strategic Initiatives
    • 8.1.4. Charles River Laboratory
      • 8.1.4.1. Company Overview
      • 8.1.4.2. Financial Performance
      • 8.1.4.3. Product Benchmarking
      • 8.1.4.4. Strategic Initiatives
    • 8.1.5. ICON Plc
      • 8.1.5.1. Company Overview
      • 8.1.5.2. Financial Performance
      • 8.1.5.3. Product Benchmarking
      • 8.1.5.4. Strategic Initiatives
    • 8.1.6. Wuxi AppTec Inc
      • 8.1.6.1. Company Overview
      • 8.1.6.2. Financial Performance
      • 8.1.6.3. Product Benchmarking
      • 8.1.6.4. Strategic Initiatives
    • 8.1.7. PRA Health Sciences
      • 8.1.7.1. Company Overview
      • 8.1.7.2. Financial Performance
      • 8.1.7.3. Product Benchmarking
      • 8.1.7.4. Strategic Initiatives
    • 8.1.8. SGS SA
      • 8.1.8.1. Company Overview
      • 8.1.8.2. Financial Performance
      • 8.1.8.3. Product Benchmarking
      • 8.1.8.4. Strategic Initiatives
    • 8.1.9. Syneos Health
      • 8.1.9.1. Company Overview
      • 8.1.9.2. Financial Performance
      • 8.1.9.3. Product Benchmarking
      • 8.1.9.4. Strategic Initiatives
    • 8.1.10. Chiltern International Ltd
      • 8.1.10.1. Company Overview
      • 8.1.10.2. Financial Performance
      • 8.1.10.3. Product Benchmarking
      • 8.1.10.4. Strategic Initiatives
    • 8.1.11. Eli Lilly and Company
      • 8.1.11.1. Company Overview
      • 8.1.11.2. Financial Performance
      • 8.1.11.3. Product Benchmarking
      • 8.1.11.4. Strategic Initiatives
    • 8.1.12. Novo Nordisk A/S
      • 8.1.12.1. Company Overview
      • 8.1.12.2. Financial Performance
      • 8.1.12.3. Product Benchmarking
      • 8.1.12.4. Strategic Initiatives
    • 8.1.13. Pfizer
      • 8.1.13.1. Company Overview
      • 8.1.13.2. Financial Performance
      • 8.1.13.3. Product Benchmarking
      • 8.1.13.4. Strategic Initiatives
    • 8.1.14. Clinipace
      • 8.1.14.1. Company Overview
      • 8.1.14.2. Financial Performance
      • 8.1.14.3. Product Benchmarking
      • 8.1.14.4. Strategic Initiatives